Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

PCSK5 promotes angiogenesis and cardiac repair after myocardial infarction.

Nature communications·2026
Same author

Food-Grade Microemulsion for High-Loading Octacosanol: Formulation Optimization, Characterization, and Biological Evaluation.

Foods (Basel, Switzerland)·2026
Same author

Exploring healthcare professionals' views on integrative Chinese-Western medicine in the nutritional management of cancer patients: a qualitative study.

Frontiers in nutrition·2026
Same author

U.S. Veteran Interest in Peer Specialists' Help to Enhance Suicide Safety Plans: Understanding Veteran Perspectives on Safety Plan Engagement.

Journal of military social work and behavioral health services·2026
Same author

Exploratory transcriptomic analysis suggests candidate genes associated with loss of response to ustekinumab in Crohn's disease.

Frontiers in genetics·2026
Same author

A rare pediatric cardiac papillary fibroelastoma: a case report.

Frontiers in cardiovascular medicine·2026

相关实验视频

Updated: Jun 2, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.2K

探索TNFR1:从发现到向治疗的开发.

Yingying Li1,2, Ruiwei Ye2, Haorui Dai2

  • 1School of Medicine, Shanghai Baoshan Luodian Hospital, Shanghai University, Shanghai, 201908, China.

Journal of translational medicine
|January 15, 2025
PubMed
概括

瘤亡因子受体1 (TNFR1) 在炎症和细胞死亡中起着关键作用. 向TNFR1为各种疾病提供了有前途的治疗策略,其副作用可能比TNF-α抑制剂少.

关键词:
细胞灭亡 (apoptosis) 是一种死亡的过程.炎症 炎症是一种炎症.这就是TNF TNF.这就是TNFR1的特点.治疗疗法 治疗疗法

更多相关视频

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.4K
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

1.8K

相关实验视频

Last Updated: Jun 2, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.2K
Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.4K
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

1.8K

科学领域:

  • 免疫学 免疫学 免疫学
  • 分子生物学分子生物学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 瘤亡因子受体1 (TNFR1) 是一个关键的细胞表面受体,调节炎症和细胞死亡途径.
  • TNFR1信号传递涉及关键途径,如核因子卡帕-B (NF-κB) 和基激活蛋白激酶 (MAPK).
  • TNFR1的失调与炎症性疾病,传染病,癌症和代谢综合征有关.

研究的目的:

  • 为了阐明TNFR1.1.的治疗潜力.
  • 提高对TNFR1在疾病发病过程中的作用的理解.
  • 探索选择性TNFR1向疗法作为TNF-α抑制的替代方案.

主要方法:

  • 对TNFR1.1的当前临床试验和临床前研究的审查.
  • 分析TNFR1信号通路及其调节机制.
  • 对调节TNFR1活性的新兴向疗法的评估.

主要成果:

  • TNFR1信号传递是各种疾病过程的核心.
  • 选择性TNFR1抑制是一种有前途的治疗途径.
  • 与TNF-α抑制剂相比,向TNFR1可能会提供更好的疗效和减少副作用.

结论:

  • TNFR1是一种具有广泛治疗潜力的重要药物标.
  • 开发TNFR1的新型治疗策略正在出现.
  • 本综述为TNFR1向治疗的未来临床应用提供了洞察力.